Comment
doi: 10.1016/S0140-6736(12)61845-5.
Epub 2012 Nov 2.
Lomitapide for homozygous familial hypercholesterolaemia
Affiliations
- PMID: 23122767
- DOI: 10.1016/S0140-6736(12)61845-5
Item in Clipboard
Comment
Lomitapide for homozygous familial hypercholesterolaemia
Lancet.
.
No abstract available
Comment on
-
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.Lancet. 2013 Jan 5;381(9860):40-6. doi: 10.1016/S0140-6736(12)61731-0. Epub 2012 Nov 2. Lancet. 2013. PMID: 23122768 Free PMC article. Clinical Trial.
Similar articles
-
Lipid-lowering treatment for homozygous familial hypercholesterolaemia--authors' reply.Lancet. 2013 Apr 6;381(9873):1183. doi: 10.1016/S0140-6736(13)60798-9. Lancet. 2013. PMID: 23561998 No abstract available.
-
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.Lancet. 2013 Jan 5;381(9860):40-6. doi: 10.1016/S0140-6736(12)61731-0. Epub 2012 Nov 2. Lancet. 2013. PMID: 23122768 Free PMC article. Clinical Trial.
-
Lipid-lowering treatment for homozygous familial hypercholesterolaemia.Lancet. 2013 Apr 6;381(9873):1182. doi: 10.1016/S0140-6736(13)60797-7. Lancet. 2013. PMID: 23561997 No abstract available.
-
Lomitapide.Am J Cardiovasc Drugs. 2011 Oct 1;11(5):347-52. doi: 10.2165/11533560-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21846156 Review.
-
Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia.Circulation. 2014 Mar 4;129(9):1022-32. doi: 10.1161/CIRCULATIONAHA.113.001292. Circulation. 2014. PMID: 24589695 Review. No abstract available.
Cited by
-
Efficacy and Safety of Lomitapide in Homozygous Familial Hypercholesterolaemia: A Systematic Review.Rev Cardiovasc Med. 2022 Apr 26;23(5):151. doi: 10.31083/j.rcm2305151. eCollection 2022 May. Rev Cardiovasc Med. 2022. PMID: 39077612 Free PMC article.
-
[Update lipidology : Evidence-based treatment of dyslipidemia].Inn Med (Heidelb). 2023 Jul;64(7):611-621. doi: 10.1007/s00108-023-01536-8. Epub 2023 Jun 15. Inn Med (Heidelb). 2023. PMID: 37318557 Free PMC article. Review. German.
-
An LDLR missense variant poses high risk of familial hypercholesterolemia in 30% of Greenlanders and offers potential of early cardiovascular disease intervention.HGG Adv. 2022 Jun 9;3(4):100118. doi: 10.1016/j.xhgg.2022.100118. eCollection 2022 Oct 13. HGG Adv. 2022. PMID: 36267056 Free PMC article.
-
Unmet Needs in LDL-C Lowering: When Statins Won't Do!Drugs. 2016 Aug;76(12):1175-90. doi: 10.1007/s40265-016-0613-0. Drugs. 2016. PMID: 27456066 Free PMC article. Review.
-
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3. Drugs. 2015. PMID: 26169307 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
